Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
Rhodes NJ, Dairem A, Moore WJ, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivak ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT. Rhodes NJ, et al. Among authors: hale cm. Am J Health Syst Pharm. 2021 Mar 18;78(7):568-577. doi: 10.1093/ajhp/zxaa426. Am J Health Syst Pharm. 2021. PMID: 33537767 Free PMC article.
Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19.
Rhodes NJ, Dairem A, Moore W, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivek ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT. Rhodes NJ, et al. Among authors: hale cm. medRxiv. 2020 Jun 5:2020.06.03.20121558. doi: 10.1101/2020.06.03.20121558. Preprint. medRxiv. 2020. PMID: 32577687 Free PMC article. Updated.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page